South Africa is grappling with a quiet, yet deadly crisis: the alarming proliferation of counterfeit and substandard medicines, known as the counterfeit medicine crisis. While the nation faces ongoing health-care challenges like rising drug prices, medicine shortages, and a strained public health system, the influx of fake drugs presents a far more insidious threat. These aren’t just ineffective placebos; they…
Tag: SAHPRA
-
Adcock Ingram’s Urizone Wins Trademark Battle
A South African court has ruled in favour of Adcock Ingram and Zambon SPA. It ordered Cipla Medpro to stop using the trademark Furizome for its urinary tract infection (UTI) medication. The court found Furizome to be confusingly similar to the established Urizone trademark, central to Adcock Ingram’s branding strategy. This led to a ruling based on trademark infringement and…
-
SAHPRA calls for Increased National Treasury funding
The SA Health Products Regulatory Authority (SAHPRA) is again seeking additional financial support from the National Treasury. Over-reliance on fee income has placed the authority in a precarious position, with CEO Boitumelo Semete stressing the risks involved during a recent presentation to parliament. The authority’s diminishing government grant and industry consolidation threaten its ability to function effectively. SAHPRA, established in…